Proud to have played a small role in a paper from @deCODEgenetics on the landscape of mitochondrial DNA mutations in human pedigrees out in Cell today.
It's ~100 times larger than any previous study of its kind, enabling many cool findings! Thread 🧵: 1/
https://t.co/S77Gb3Yjiv
Exp 71 explored ways to treat neurological disorders and continued spacewalk preps while packing a U.S. cargo craft on Monday. More... https://t.co/RsxgfgUmax
NASA Astronaut Mike Barratt prepared HBOND for cold stowage aboard the @Space_Station. HBOND studies brain organoid models to help improve our understanding of neurodegenerative diseases. It could lead to the development of new therapies. Read about HBOND: https://t.co/L2gRsUq2oj
To better understand #neurodegenerative diseases like #parkinsons and #ms, researchers from the @nationalscf are sending miniature 3D models of the human brain to the @Space_station. Research results could ultimately benefit millions of people worldwide: https://t.co/zr4e1mBBwU
We are delighted to announce our new President & CEO, Jennifer J. Raab! She brings an extensive track record of advancing scientific research and education, and we look forward to NYSCF's next era under her experienced leadership. Welcome @nyscfpresident! https://t.co/Ja7SHA38Iu
Do we have PIGs in our brains? This seems like a strange question, but it’s an important one, and the answer helps us understand how Alzheimer’s disease develops.
@HaselPhilip decided to investigate - and it's published today: https://t.co/Mw0JdnXA2x
(thread: 1/9)
Susan L. Solomon passed away peacefully on Sep. 8, 2022 after a long battle with ovarian cancer. The memorial service remembering her wide-reaching impact can be viewed here:
https://t.co/uEUYKCQfdr
Our new study is out in @NatureNeuro feat. the first-ever #stemcell model of #PTSD in collaboration w/ NYSCF – Robertson #StemCell Investigator Alumna @KristenBrennand & led by @RachelYehuda — discovering new disease features w/ implications for therapies: https://t.co/JrG3D6sMJ5
I'm so grateful to @WSJ for this fantastic piece about Susan and her remarkable life: A lawyer and business executive found her calling in stem-cell research https://t.co/A2hYO7u1ZP via @WSJ
A touching obituary of our beloved founding CEO, Susan L. Solomon, in today's @nytimes:
“Vexed by lags in producing cures for diabetes and cancer, she helped raise $400M to start a foundation that has made breakthroughs in treating major diseases.” (1/n)
https://t.co/9MTSUtFH9w
Immensely saddened to loose Susan. She remains an inspiration and a mentor who challenged me to grow and to make the seemingly impossible possible. I and all of us @nyscf will miss her greatly.
With a very heavy heart, we announce the passing of our CEO and co-founder, Susan Solomon, following a long battle with ovarian cancer. We owe all that NYSCF has accomplished to Susan, and no words can express our gratitude and awe for her catalytic impact on stem cell research.